Product Program year 2019 Source: CMS Open Payments

Azurion 7 M20

Device Cardiology/Vascular Diseases

Open in the dashboard

General payments

$12,814

124 payments

Research payments

$0

0 payments

Through program year 2019, $12,814 in general payments and $0 in research payments were reported against Azurion 7 M20 (Cardiology/Vascular Diseases).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2019 General $12,814 124

Breakdown

Who paid General payments · program year 2019
  1. Philips Electronics North America Corporation $12,814 124 payments
Top recipients General payments · program year 2019
  1. Sergio Waxman Interventional Cardiology · Burlington, MA $790 6% · 6 payments
  2. Jeffrey Lautin Vascular & Interventional Radiology · West Orange, NJ $790 6% · 6 payments
  3. Adam Kopelan Millburn, NJ $790 6% · 6 payments
  4. Robert March Thoracic Surgery (Cardiothoracic Vascular Surgery) · Chicago, IL $758 6% · 2 payments
  5. Stephen Reed Interventional Cardiology · Fort Wayne, IN $740 6% · 7 payments

The top 5 of 64 recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Interventional Cardiology Internal Medicine $3,395 28% · 14 practitioners
  2. Vascular Surgery Surgery $3,175 26% · 9 practitioners
  3. Vascular & Interventional Radiology Radiology $2,350 20% · 15 practitioners
  4. Diagnostic Radiology Radiology $948 8% · 7 practitioners
  5. Thoracic Surgery (Cardiothoracic Vascular Surgery) $822 7% · 3 practitioners

The top 5 of 11 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. Indiana $2,991 23% · 7 recipients
  2. New Jersey $2,187 17% · 4 recipients
  3. Georgia $1,587 12% · 15 recipients
  4. New York $1,266 10% · 4 recipients
  5. Massachusetts $790 6% · 1 recipient

The top 5 of 22 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

124 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record